Difference between revisions of "Template:Acetylcholine receptor modulators"

From blackwiki
Jump to navigation Jump to search
blackwiki>Zakblade2000
(added anatoxin-a(S))
blackwiki>Medgirl131
Line 13: Line 13:
 
  | groupstyle = text-align:center;
 
  | groupstyle = text-align:center;
  
   | group1 = [[Muscarinic acetylcholine receptor|mACh]]
+
   | group1 = {{abbrlink|mACh|Muscarinic acetylcholine receptors}}
 
   | list1 =
 
   | list1 =
 
* '''Agonists:''' [[77-LH-28-1]]
 
* '''Agonists:''' [[77-LH-28-1]]
Line 163: Line 163:
 
* [[Zamifenacin]]
 
* [[Zamifenacin]]
  
   | group2 = [[Nicotinic acetylcholine receptor|nACh]]
+
   | group2 = {{abbrlink|nACh|Nicotinic acetylcholine receptors}}
 
   | list2 =
 
   | list2 =
 
* '''Agonists:''' [[5-Hydroxyindoleacetic acid|5-HIAA]]
 
* '''Agonists:''' [[5-Hydroxyindoleacetic acid|5-HIAA]]
Line 330: Line 330:
 
  | groupstyle = text-align:center;
 
  | groupstyle = text-align:center;
  
   | group1 = [[Choline transporter|CHT]]
+
   | group1 = {{abbrlink|CHT|Choline transporter}}
 
   | list1 =
 
   | list1 =
 
* '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]]
 
* '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]]
Line 337: Line 337:
 
* '''Enhancers:''' [[Coluracetam]]
 
* '''Enhancers:''' [[Coluracetam]]
  
   | group2 = [[Vesicular acetylcholine transporter|VAChT]]
+
   | group2 = {{abbrlink|VAChT|Vesicular acetylcholine transporter}}
 
   | list2 =
 
   | list2 =
 
* '''Inhibitors:''' [[Vesamicol]]
 
* '''Inhibitors:''' [[Vesamicol]]
Line 349: Line 349:
 
  | groupstyle = text-align:center;
 
  | groupstyle = text-align:center;
  
   | group1 = [[Choline acetyltransferase|ChAT]]
+
   | group1 = {{abbrlink|ChAT|Choline acetyltransferase}}
 
   | list1 =
 
   | list1 =
 
* '''Inhibitors:''' [[1-(-Benzoylethyl)pyridinium]]
 
* '''Inhibitors:''' [[1-(-Benzoylethyl)pyridinium]]
Line 364: Line 364:
 
* [[N,N-Dimethylaminoethylchloroacetate]]
 
* [[N,N-Dimethylaminoethylchloroacetate]]
  
   | group2 = [[Acetylcholinesterase|AChE]]
+
   | group2 = {{abbrlink|AChE|Acetylcholinesterase}}
 
   | list2 =
 
   | list2 =
 
* '''Inhibitors:''' ''Reversible:'' Carbamates: [[Aldicarb]]
 
* '''Inhibitors:''' ''Reversible:'' Carbamates: [[Aldicarb]]
Line 488: Line 488:
 
* [[Pralidoxime]]
 
* [[Pralidoxime]]
  
   | group3 = [[Butyrylcholinesterase|BChE]]
+
   | group3 = {{abbrlink|BChE|Butyrylcholinesterase}}
 
   | list3 =
 
   | list3 =
 
* '''Inhibitors:''' [[Cymserine]]
 
* '''Inhibitors:''' [[Cymserine]]
Line 503: Line 503:
 
   | group1 = [[Release inhibitor|Inhibitors]]
 
   | group1 = [[Release inhibitor|Inhibitors]]
 
   | list1 =
 
   | list1 =
* '''[[Synaptosomal-associated protein 25|SNAP-25]] inactivators:''' [[Botulinum toxin]] ([[Botulinum toxin A|A]], [[Botulinum toxin C|C]], [[Botulinum toxin E|E]])
+
* '''{{abbrlink|SNAP-25|Synaptosomal-associated protein 25}} inactivators:''' [[Botulinum toxin]] ([[Botulinum toxin A|A]], [[Botulinum toxin C|C]], [[Botulinum toxin E|E]])
* '''[[Vesicle-associated membrane protein|VAMP]] inactivators:''' [[Botulinum toxin]] ([[Botulinum toxin B|B]], [[Botulinum toxin D|D]], [[Botulinum toxin F|F]], [[Botulinum toxin G|G]])
+
* '''{{abbrlink|VAMP|Vesicle-associated membrane protein}} inactivators:''' [[Botulinum toxin]] ([[Botulinum toxin B|B]], [[Botulinum toxin D|D]], [[Botulinum toxin F|F]], [[Botulinum toxin G|G]])
 
* '''Others:''' [[Bungarotoxin]]s ([[Beta-Bungarotoxin|β-bungarotoxin]], [[γ-bungarotoxin]])
 
* '''Others:''' [[Bungarotoxin]]s ([[Beta-Bungarotoxin|β-bungarotoxin]], [[γ-bungarotoxin]])
  
 
   | group2 = [[Release enhancer|Enhancers]]
 
   | group2 = [[Release enhancer|Enhancers]]
 
   | list2 =
 
   | list2 =
* '''[[Latrophilin|LPHN]] agonists:''' [[Alpha-Latrotoxin|α-Latrotoxin]]
+
* '''{{abbrlink|LPHN|Latrophilin}} agonists:''' [[Alpha-Latrotoxin|α-Latrotoxin]]
 
* '''Others:''' [[Atracotoxin]] (e.g., [[robustoxin]], [[versutoxin]])
 
* '''Others:''' [[Atracotoxin]] (e.g., [[robustoxin]], [[versutoxin]])
 
* [[Crotoxin]]
 
* [[Crotoxin]]

Revision as of 09:38, 27 August 2017

Template documentation

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Acetylcholine receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Acetylcholine receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Acetylcholine receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.

How to manage this template's collapsible groups/sections option
  • This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter |name where name is one of the following words that identify the groups/sections (omit any speech or quotation marks):
    • Receptor
    • Transporter
    • Inhibitors
    • Others
  • For example: {{Acetylcholine receptor modulators |Receptor}}
sr:Шаблон:Холинергици